Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 2.829 | 2.722 | 0.09302 | 0.65294 | |
RegionR2 | 3.683 | 2.722 | 0.00028 | 0.00849 | |
RegionR3 | 2.188 | 2.722 | 0.00566 | 0.10374 | |
RegionR4 | -0.885 | 2.722 | 0.98001 | 1.00000 | |
RegionR5 | -1.228 | 2.722 | 0.99094 | 1.00000 | |
RegionR6 | -0.605 | 2.722 | 0.94856 | 1.00000 | |
RegionR7 | -0.927 | 2.722 | 0.97741 | 1.00000 | |
RegionR8 | -5.053 | 2.722 | 0.11592 | 0.62896 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -7.728 | 2.722 | 0.04183 | 0.67581 | |
RegenerationR2 | -1.024 | 2.722 | 0.04455 | 0.34892 | |
RegenerationR3 | -1.126 | 2.722 | 0.07718 | 0.45966 | |
RegenerationR4 | -1.833 | 2.722 | 0.09526 | 0.48010 | |
RegenerationR5 | -2.517 | 2.722 | 0.03665 | 0.31750 | |
RegenerationR6 | -1.251 | 2.722 | 0.25912 | 0.60940 | |
RegenerationBL | -3.376 | 2.722 | 1.00000 | 1.00000 | |
RegenerationTP | -2.478 | 2.722 | 0.99966 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
2. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 5.201 | 0.810 | 0.793 | 0.802 | 0.938 | 0.879 | 0.979 | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
3. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 4.701 | 0.940 | 0.914 | - | 0.956 | 0.891 | 1.000 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
4. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 4.59 | 0.956 | - | 0.922 | 0.901 | 0.831 | 0.980 | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
5. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
4.589 | 0.891 | 0.832 | - | 0.949 | 0.935 | 0.982 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
6. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 4.588 | 0.941 | 0.766 | - | 0.985 | 0.902 | 0.994 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
7. | MligTC455_15467 | 225 | 4.69 | Mlig455_000546 | Neo: - Age: Down-Up-Up Region-specific R2: 6.857 Region-enriched R2: 5.997/0.00105 |
4.556 | 0.946 | 0.827 | - | 0.983 | 0.884 | 0.916 | Mlig455_000546 {REF} {Length: 844} {Pfam: Pancreatic hormone peptide [PF00159.20, score=42.9]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=39.7, Expect=1e-05]} {RNA1310_53697} {RNA815_26198} | |
8. | MligTC455_25928 | 181 | 3.78 | Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700 | Neo: - Age: logFC(26M/2M)=-0.528 Region-specific R2: 7.256 Region-enriched R2: 5.788/0.02697 |
4.549 | - | 0.839 | 0.875 | 0.930 | 0.935 | 0.970 | Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957} Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2} |
|
9. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 4.541 | 0.787 | - | 0.912 | 0.944 | 0.941 | 0.957 | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
10. | MligTC455_22214 | 237 | 4.94 | Mlig455_019333, Mlig455_019447 | Neo: - Age: - |
NRG2 | 4.413 | - | 0.852 | 0.851 | 0.954 | 0.980 | 0.776 | Mlig455_019333 {REF} {Length: 4291} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=50.5]; Immunoglobulin domain [PF13927.8, score=44.7]; Immunoglobulin domain [PF00047.27, score=43.9]; Immunoglobulin domain [PF13895.8, score=22.0]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=86.7, Expect=8e-17]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [RH, Score=81.3, Expect=2e-15]} {Dmel: FBgn0005666, bt, bent, [Score=52.0, Expect=2e-06]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=51.2, Expect=3e-06]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [Score=55.1, Expect=9e-08]} {RNA1509_54517} {RNA1310_8322} {RNA815_13786} Mlig455_019447 {REF} {Length: 4242} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=50.5]; Immunoglobulin domain [PF13927.8, score=44.8]; Immunoglobulin domain [PF00047.27, score=43.9]; Immunoglobulin domain [PF13895.8, score=22.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=18.6]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=88.6, Expect=2e-17]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [RH, Score=83.2, Expect=7e-16]} {Dmel: FBgn0005666, bt, bent, [Score=52.4, Expect=2e-06]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=51.2, Expect=3e-06]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [Score=55.1, Expect=9e-08]} {RNA1509_54517} {RNA1310_8322} {RNA815_13786} |
11. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 4.408 | 0.868 | 0.882 | - | 0.829 | 0.833 | 0.996 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
12. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 4.407 | 0.809 | - | 0.832 | 0.979 | 0.832 | 0.955 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
13. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
4.391 | 0.887 | 0.882 | - | 0.799 | 0.827 | 0.996 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
14. | MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
4.378 | 0.857 | 0.831 | - | 0.891 | 0.834 | 0.965 | Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} | |
15. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
4.359 | 0.809 | 0.735 | - | 0.949 | 0.886 | 0.980 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
16. | MligTC455_32582 | 524 | 10.91 | Mlig455_010043 | Neo: - Age: - |
SH3GL1 | 4.35 | 0.746 | - | 0.883 | 0.891 | 0.965 | 0.865 | Mlig455_010043 {REF} {Length: 4371} {Pfam: BAR domain [PF03114.20, score=223.0]; SH3 domain [PF00018.30, score=50.0]; Variant SH3 domain [PF14604.8, score=49.3]; Bin/amphiphysin/Rvs domain for vesicular trafficking [PF10455.11, score=48.7]; Variant SH3 domain [PF07653.19, score=45.4]} {Human: ENSG00000141985, SH3GL1, SH3 domain containing GRB2 like 1, endophilin A2, [RH, Score=348, Expect=4e-118]; ENSG00000140600, SH3GL3, SH3 domain containing GRB2 like 3, endophilin A3, [RH, Score=339, Expect=8e-115]} {Mouse: ENSMUSG00000003200, Sh3gl1, SH3-domain GRB2-like 1, [RH, Score=344, Expect=2e-116]} {Dmel: FBgn0038659, EndoA, Endophilin A, [RH, Score=76.6, Expect=3e-15]} {Celegans: WBGene00006791, unc-57, Endophilin-A homolog, [RH, Score=328, Expect=3e-110]} {Smed: dd_Smed_v6_6372_0_1, dd_Smed_v6_6372_0_1, [RH, Score=391, Expect=2e-135]} {RNA1509_53264} {RNA1310_24751} {RNA815_11391.1} |
17. | MligTC455_50594 | 440 | 9.18 | Mlig455_010362 | Neo: - Age: Down-Up-Up Region-specific R2: 4.701 Region-enriched R2: 4.104/0.00000 |
4.316 | - | 0.707 | 0.828 | 0.967 | 0.919 | 0.895 | Mlig455_010362 {REF} {Length: 685} {RNA1509_30018} {RNA1310_56512.2} {RNA815_28562} | |
18. | MligTC455_50532 | 259 | 5.4 | Mlig455_019987 | Neo: - Age: Down-Up-Down |
NEFH | 4.296 | - | 0.906 | 0.727 | 0.875 | 0.831 | 0.957 | Mlig455_019987 {REF} {Length: 4055} {Human: ENSG00000100285, NEFH, neurofilament heavy, [Score=65.5, Expect=3e-10]} {RNA1509_41200, RNA1509_57173} {RNA1310_3614.2, RNA1509_41200, RNA1509_57173} {RNA1509_41200, RNA1509_57173, RNA815_5328} |
19. | MligTC455_40658 | 152 | 3.17 | Mlig455_064614 | Neo: - Age: - |
CLIP2 | 4.292 | 0.755 | 0.907 | - | 0.823 | 0.834 | 0.973 | Mlig455_064614 {REF} {Length: 2460} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=9e-10]} {Dmel: FBgn0036882, CG9279, [Score=55.1, Expect=9e-08]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746} |
20. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
4.282 | 0.748 | 0.770 | - | 0.981 | 0.821 | 0.962 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
21. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 4.267 | 0.722 | - | 0.904 | 0.940 | 0.750 | 0.951 | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
22. | MligTC455_47806 | 2724 | 56.76 | Mlig455_033677 | Neo: - Age: - Region-specific R2: 3.773 Region-enriched R2: 2.504/0.00005 |
4.226 | - | 0.710 | 0.758 | 0.973 | 0.912 | 0.873 | Mlig455_033677 {REF} {Length: 1836} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1310_30659.1, RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504, RNA815_13807} | |
23. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
4.216 | 0.835 | 0.865 | - | 0.750 | 0.778 | 0.988 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
24. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
4.185 | 0.769 | 0.742 | - | 0.984 | 0.952 | 0.738 | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
25. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 4.18 | 0.710 | 0.828 | - | 0.960 | 0.827 | 0.855 | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
26. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 4.179 | 0.765 | 0.715 | - | 0.839 | 0.964 | 0.896 | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
27. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
4.087 | 0.760 | 0.736 | - | 0.956 | 0.804 | 0.831 | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
28. | MligTC455_50099 | 170 | 3.55 | Mlig455_030606, Mlig455_030681 | Neo: - Age: Up-Down-Down |
SLC4A11 | 4.074 | 0.716 | - | 0.858 | 0.808 | 0.719 | 0.973 | Mlig455_030606 {REF} {Length: 3525} {Pfam: HCO3- transporter family [PF00955.23, score=528.0]; Band 3 cytoplasmic domain [PF07565.15, score=23.9]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=22.2]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=553, Expect=0.0]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=540, Expect=2e-179]} {Dmel: FBgn0259111, Ndae1, Na[+]-driven anion exchanger 1, [Score=239, Expect=4e-66]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=685, Expect=0.0]} {Smed: dd_Smed_v6_16577_0_1, dd_Smed_v6_16577_0_1, [RH, Score=899, Expect=0.0]} {RNA1509_55902} {RNA1310_18543} {RNA815_14015} Mlig455_030681 {REF} {Length: 2174} {Pfam: HCO3- transporter family [PF00955.23, score=526.7]; Band 3 cytoplasmic domain [PF07565.15, score=23.8]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=22.0]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=547, Expect=3e-180]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=533, Expect=2e-175]} {Dmel: FBgn0259111, Ndae1, Na[+]-driven anion exchanger 1, [Score=242, Expect=3e-66]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=680, Expect=0.0]} {Smed: dd_Smed_v6_16577_0_1, dd_Smed_v6_16577_0_1, [RH, Score=904, Expect=0.0]} {RNA1509_55902} {RNA1310_18543} {RNA815_14015} |
29. | MligTC455_08837 | 2734 | 56.96 | Mlig455_047253, Mlig455_047306 | Neo: - Age: - Region-specific R2: 4.689 Region-enriched R2: 4.490/0.00000 |
3.999 | - | 0.719 | 0.764 | 0.728 | 0.837 | 0.951 | Mlig455_047253 {REF} {Length: 3106} {TRANSSPLICED} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.0]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=41.6, Expect=3e-06]} {RNA1509_19067, RNA1509_27231} {RNA1310_388.2, RNA1509_19067} {RNA1509_19067, RNA815_3901} Mlig455_047306 {REF} {Length: 3098} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.0]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=42.0, Expect=2e-06]} {RNA1509_27231} {RNA1310_388.2, RNA1509_27231} {RNA1509_27231, RNA815_3901} |
|
30. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 3.954 | 0.736 | 0.801 | - | 0.730 | 0.721 | 0.966 | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
31. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 3.881 | 0.717 | 0.776 | - | 0.705 | 0.966 | 0.717 | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
32. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
3.782 | 0.940 | - | - | 0.958 | 0.892 | 0.992 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
33. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 3.726 | 0.884 | - | - | 0.971 | 0.894 | 0.977 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
34. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
3.723 | - | 0.837 | - | 0.968 | 0.958 | 0.960 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
35. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
3.695 | - | 0.804 | - | 0.976 | 0.945 | 0.970 | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
36. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
3.688 | 0.921 | 0.855 | - | 0.938 | - | 0.974 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
37. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
3.683 | - | 0.782 | - | 0.941 | 0.966 | 0.994 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
38. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
3.653 | - | - | 0.838 | 0.988 | 0.874 | 0.953 | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
39. | MligTC455_53189 | 1040 | 21.66 | Mlig455_029623 | Neo: - Age: Down-Down-Up |
3.653 | - | 0.854 | 0.906 | 0.974 | 0.919 | - | Mlig455_029623 {REF} {Length: 1190} {Pfam: Globin [PF00042.24, score=53.3]} {Smed: dd_Smed_v6_19850_0_1, dd_Smed_v6_19850_0_1, [Score=45.4, Expect=8e-06]} {RNA1509_20726, RNA1509_38771, RNA1509_38994} {RNA1310_34513, RNA1509_20726, RNA1509_38771, RNA1509_38994} {RNA1509_20726, RNA1509_38771, RNA1509_38994, RNA815_16338} | |
40. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 3.641 | 0.735 | - | - | 0.973 | 0.935 | 0.998 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
41. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 3.641 | 0.735 | - | - | 0.975 | 0.933 | 0.998 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
42. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
3.636 | - | 0.749 | - | 0.975 | 0.936 | 0.976 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
43. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
3.635 | - | 0.791 | - | 0.985 | 0.886 | 0.973 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
44. | MligTC455_12032 | 92 | 1.91 | Mlig455_044477 | Neo: - Age: - |
KCNIP1 | 3.61 | - | 0.880 | - | 0.909 | 0.978 | 0.843 | Mlig455_044477 {REF} {Length: 1077} {Pfam: EF hand [PF00036.34, score=60.1]; EF-hand domain [PF13405.8, score=57.2]; EF-hand domain pair [PF13499.8, score=54.7]; EF-hand domain pair [PF13833.8, score=47.2]; EF hand [PF13202.8, score=43.0]} {Human: ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=169, Expect=9e-52]; ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=164, Expect=7e-49]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=170, Expect=2e-52]} {Dmel: FBgn0039380, CG5890, [Score=150, Expect=5e-45]} {Celegans: WBGene00008998, ncs-4, Neuronal Calcium Sensor family, [RH, Score=121, Expect=1e-33]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=163, Expect=6e-50]} {RNA1310_40826} {RNA815_29104} |
45. | MligTC455_45487 | 110 | 2.3 | Mlig455_004129, Mlig455_060457 | Neo: - Age: - |
3.602 | - | - | 0.898 | 0.887 | 0.847 | 0.970 | Mlig455_004129 {REF} {Length: 1131} {Pfam: PAN domain [PF00024.28, score=18.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1310_37660} {RNA815_17816.1} Mlig455_060457 {REF} {Length: 1507} {Pfam: PAN domain [PF00024.28, score=19.5]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1509_54623} {RNA1310_33480} {RNA815_17816.1} |
|
46. | MligTC455_18564 | 196 | 4.08 | Mlig455_063527 | Neo: - Age: - Region-enriched R2: 2.416/0.01839 |
PRKG2 | 3.599 | - | - | 0.892 | 0.928 | 0.819 | 0.960 | Mlig455_063527 {REF} {Length: 2971} {Pfam: Protein kinase domain [PF00069.27, score=212.4]; Cyclic nucleotide-binding domain [PF00027.31, score=135.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.7]; Kinase-like [PF14531.8, score=24.8]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=653, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=651, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=662, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=655, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=645, Expect=0.0]} {RNA1509_38353} {RNA1310_8466, RNA1509_38353} {RNA1509_38353, RNA815_6313} |
47. | MligTC455_48848 | 282 | 5.87 | Mlig455_005151, Mlig455_021613 | Neo: - Age: - Region-specific R2: 4.764 Region-enriched R2: 5.813/0.00000 |
SYT3 | 3.591 | - | 0.736 | - | 0.986 | 0.886 | 0.983 | Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} |
48. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
3.587 | 0.940 | 0.700 | - | 0.979 | - | 0.968 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
49. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
3.586 | - | 0.720 | - | 0.965 | 0.910 | 0.991 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
50. | MligTC455_41382 | 65 | 1.35 | Mlig455_022554 | Neo: - Age: - Region-enriched R2: 5.596/0.01432 |
3.582 | - | - | 0.918 | 0.946 | 0.750 | 0.968 | Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745} | |
51. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
3.581 | 0.943 | 0.714 | - | - | 0.936 | 0.988 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
52. | MligTC455_23150 | 3195 | 66.56 | Mlig455_009524, Mlig455_009530 | Neo: - Age: - Region-enriched R2: 3.504/0.00000 |
CDK16 | 3.575 | - | 0.721 | - | 0.968 | 0.980 | 0.906 | Mlig455_009524 {REF} {Length: 3287} {Pfam: Protein kinase domain [PF00069.27, score=218.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.2]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [RH, Score=463, Expect=7e-159]; ENSG00000059758, CDK17, cyclin dependent kinase 17, [RH, Score=447, Expect=2e-151]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [RH, Score=464, Expect=2e-158]; ENSMUSG00000020015, Cdk17, cyclin-dependent kinase 17, [RH, Score=449, Expect=2e-152]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=362, Expect=2e-118]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [RH, Score=417, Expect=3e-138]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [RH, Score=449, Expect=6e-151]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} Mlig455_009530 {REF} {Length: 3384} {Pfam: Protein kinase domain [PF00069.27, score=208.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.4]; Haspin like kinase domain [PF12330.10, score=17.8]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [Score=432, Expect=5e-147]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [Score=431, Expect=4e-146]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=329, Expect=9e-107]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [Score=392, Expect=2e-130]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [Score=411, Expect=6e-137]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} |
53. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
3.574 | - | 0.789 | - | 0.985 | 0.832 | 0.968 | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
54. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
3.574 | - | 0.786 | - | 0.889 | 0.909 | 0.990 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
55. | MligTC455_46341 | 243 | 5.06 | Mlig455_052880, Mlig455_052884 | Neo: - Age: - |
3.574 | 0.823 | - | - | 0.958 | 0.820 | 0.973 | Mlig455_052880 {REF} {Length: 1228} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=28.6]; Dpy-30 motif [PF05186.15, score=22.0]; Ankyrin repeats (many copies) [PF13637.8, score=20.9]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=60.5, Expect=6e-10]} {RNA1509_39973} {RNA1310_21889} {RNA815_13094} Mlig455_052884 {REF} {Length: 1926} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=39.4]; Ankyrin repeats (many copies) [PF13637.8, score=27.7]; Ankyrin repeats (many copies) [PF13857.8, score=24.6]; Dpy-30 motif [PF05186.15, score=21.6]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=72.8, Expect=1e-13]} {RNA1509_39973} {RNA1310_21889, RNA1509_39973} {RNA1509_39973, RNA815_13094} |
|
56. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
3.567 | 0.916 | - | - | 0.907 | 0.792 | 0.952 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
57. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 3.565 | 0.888 | - | - | 0.939 | 0.787 | 0.951 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
58. | MligTC455_37315 | 84 | 1.76 | Mlig455_048842 | Neo: - Age: - |
CALM2 | 3.563 | - | - | 0.859 | 0.787 | 0.966 | 0.951 | Mlig455_048842 {REF} {Length: 1287} {Pfam: EF-hand domain pair [PF13499.8, score=22.7]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=68.9, Expect=6e-14]; ENSG00000198668, CALM1, calmodulin 1, [Score=68.2, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=66.6, Expect=2e-13]; ENSG00000178363, CALML3, calmodulin like 3, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=2e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=66.6, Expect=1e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=66.6, Expect=1e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=68.6, Expect=1e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=68.6, Expect=1e-14]} {Smed: dd_Smed_v6_5491_0_1, dd_Smed_v6_5491_0_1, [Score=110, Expect=3e-30]} {RNA1310_33365} {RNA815_27013} |
59. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
3.563 | - | 0.834 | - | 0.970 | 0.930 | 0.829 | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
60. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 3.562 | - | - | 0.826 | 0.948 | 0.794 | 0.994 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
61. | MligTC455_39064 | 110 | 2.28 | Mlig455_000222, Mlig455_058480 | Neo: Irradiation Age: - Region-enriched R2: 5.418/0.00017 |
OSBPL1A | 3.561 | - | 0.776 | - | 0.993 | 0.863 | 0.929 | Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740} Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411} |
62. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
3.56 | - | 0.739 | - | 0.967 | 0.891 | 0.963 | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
63. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 3.556 | 0.846 | - | - | 0.928 | 0.801 | 0.981 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
64. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 3.546 | 0.893 | - | - | 0.807 | 0.853 | 0.993 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
65. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
3.545 | - | 0.833 | - | 0.984 | 0.772 | 0.956 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
66. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
3.543 | - | 0.749 | - | 0.916 | 0.921 | 0.957 | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
67. | MligTC455_52727 | 82 | 1.72 | Mlig455_043336 | Neo: - Age: Down-Up-Down |
3.543 | 0.930 | - | - | 0.855 | 0.985 | 0.773 | Mlig455_043336 {REF} {Length: 1410} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=60.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=20.9]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=131, Expect=4e-35]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
68. | MligTC455_20574 | 3347 | 69.74 | Mlig455_021418 | Neo: - Age: - |
PCSK2 | 3.542 | - | 0.771 | - | 0.966 | 0.892 | 0.913 | Mlig455_021418 {REF} {Length: 1212} {Pfam: Peptidase S8 pro-domain [PF16470.7, score=47.7]} {Human: ENSG00000125851, PCSK2, proprotein convertase subtilisin/kexin type 2, [Score=53.9, Expect=2e-08]} {Mouse: ENSMUSG00000027419, Pcsk2, proprotein convertase subtilisin/kexin type 2, [Score=52.8, Expect=4e-08]} {Dmel: FBgn0023179, amon, amontillado, [Score=55.8, Expect=2e-09]} {Celegans: WBGene00001172, egl-3, Neuroendocrine convertase 2, [Score=61.2, Expect=3e-11]} {Smed: dd_Smed_v6_1566_0_1, dd_Smed_v6_1566_0_1, [Score=65.1, Expect=1e-12]} {RNA1509_15978} {RNA1310_7333.1} {RNA815_2403.2} |
69. | MligTC455_23957 | 33 | 0.68 | Mlig455_015196, Mlig455_068736 | Neo: - Age: - Region-enriched R2: 7.683/0.01527 |
3.539 | - | 0.785 | - | 0.948 | 0.838 | 0.968 | Mlig455_015196 {REF} {Length: 1138} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.8]} {RNA1509_30941} {RNA1310_34740} {RNA815_15663} Mlig455_068736 {REF} {Length: 1580} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=64.0]} {RNA1310_32395.1} {RNA815_15663} |
|
70. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
3.534 | - | 0.815 | - | 0.964 | 0.930 | 0.825 | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
71. | MligTC455_25914 | 4684 | 97.58 | Mlig455_004975 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.418 Region-enriched R2: 1.471/0.00163 Regeneration-downregulated BL: -1.843 Regeneration-depleted BL: -1.843 |
3.528 | - | 0.736 | - | 0.973 | 0.933 | 0.886 | Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1} | |
72. | MligTC455_46067 | 548 | 11.42 | Mlig455_054518, Mlig455_055436, Mlig455_055448 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.305/0.04262 |
GRIK3, GRIK4 | 3.523 | - | - | 0.807 | 0.873 | 0.881 | 0.962 | Mlig455_054518 {REF} {Length: 4725} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=91.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.2]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=222, Expect=5e-60]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=222, Expect=6e-60]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=218, Expect=3e-58]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=216, Expect=3e-58]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=215, Expect=1e-57]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=213, Expect=9e-57]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=213, Expect=9e-57]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=224, Expect=2e-60]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=224, Expect=9e-61]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=220, Expect=2e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=216, Expect=2e-58]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=215, Expect=1e-57]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=296, Expect=6e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=312, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_14215, RNA1509_40992} {RNA1310_5620.1, RNA1509_14215, RNA1509_40992} {RNA1509_14215, RNA1509_40992, RNA815_1965} Mlig455_055436 {REF} {Length: 4732} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=90.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=219, Expect=6e-59]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=218, Expect=7e-59]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=218, Expect=7e-59]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=216, Expect=3e-58]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=216, Expect=9e-58]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=211, Expect=2e-56]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=209, Expect=1e-55]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=226, Expect=3e-61]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=221, Expect=1e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=216, Expect=2e-58]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=216, Expect=2e-58]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=216, Expect=3e-58]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=297, Expect=2e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_40992} {RNA1310_5620.1} {RNA815_1965} Mlig455_055448 {REF} {Length: 4726} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=90.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=219, Expect=9e-59]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=218, Expect=9e-59]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=218, Expect=8e-59]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=217, Expect=2e-58]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=216, Expect=7e-58]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=213, Expect=6e-57]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=209, Expect=1e-55]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=225, Expect=4e-61]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=221, Expect=1e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=217, Expect=9e-59]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=216, Expect=5e-58]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=216, Expect=3e-58]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=297, Expect=2e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_32892, RNA1509_40992} {RNA1310_5620.1, RNA1509_32892} {RNA1509_32892, RNA815_1965} |
73. | MligTC455_47716 | 1445 | 30.1 | Mlig455_062374, Mlig455_062397 | Neo: - Age: Down-Up-Up Region-specific R2: 4.444 Region-enriched R2: 3.549/0.00000 |
3.521 | - | 0.808 | - | 0.959 | 0.857 | 0.897 | Mlig455_062374 {REF} {Length: 899} {RNA1509_16194} {RNA1310_50819.1} {RNA815_25538} Mlig455_062397 {REF} {Length: 907} {RNA1509_16194} {RNA1310_50819.1, RNA1509_16194} {RNA1509_16194, RNA815_25538} |
|
74. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 3.519 | 0.703 | - | - | 0.910 | 0.927 | 0.979 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
75. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
3.515 | - | 0.744 | - | 0.963 | 0.956 | 0.852 | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
76. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 3.512 | - | 0.736 | - | 0.969 | 0.938 | 0.869 | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
77. | MligTC455_24272 | 197 | 4.1 | Mlig455_005121, Mlig455_005189 | Neo: - Age: Down-Up-Down |
CHRNA7 | 3.505 | - | 0.836 | 0.895 | 0.963 | - | 0.811 | Mlig455_005121 {REF} {Length: 1737} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=104.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=135, Expect=4e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=134, Expect=3e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=134, Expect=3e-34]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=131, Expect=3e-33]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=127, Expect=5e-32]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=119, Expect=6e-29]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=129, Expect=1e-32]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=120, Expect=2e-29]} {RNA1509_43533} {RNA1310_19997.1, RNA1509_43533} {RNA1509_43533, RNA815_7971} Mlig455_005189 {REF} {Length: 1477} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.4]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=2e-34]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=133, Expect=8e-34]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=128, Expect=4e-32]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=117, Expect=4e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=130, Expect=1e-32]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=117, Expect=3e-28]} {RNA1509_43533} {RNA1310_19997.1} {RNA815_7971} |
78. | MligTC455_41028 | 108 | 2.26 | Mlig455_033278 | Neo: - Age: - |
3.505 | 0.943 | 0.724 | - | 0.868 | - | 0.970 | Mlig455_033278 {REF} {Length: 1134} {Pfam: PAN domain [PF00024.28, score=19.4]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=9e-14]} {RNA1310_31986} {RNA815_17816.2} | |
79. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
3.503 | - | 0.730 | - | 0.941 | 0.850 | 0.982 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
80. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 3.498 | - | 0.752 | - | 0.958 | 0.952 | 0.836 | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
81. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 3.496 | - | 0.759 | - | 0.955 | 0.948 | 0.834 | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
82. | MligTC455_53581 | 10826 | 225.54 | Mlig455_061865 | Neo: - Age: Down-Down-Up Region-specific R2: 2.296 Region-enriched R2: 1.603/0.00040 Regeneration-downregulated BL: -1.690 Regeneration-depleted BL: -1.690 |
3.491 | - | 0.809 | - | 0.952 | 0.908 | 0.822 | Mlig455_061865 {REF} {Length: 1605} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=82.0]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=1e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=4e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=118, Expect=1e-31]} {RNA1509_1202, RNA1509_24767} {RNA1310_24594, RNA1509_24767} {RNA1509_24767, RNA815_8289} | |
83. | MligTC455_49793 | 54 | 1.12 | Mlig455_000683, Mlig455_000735, Mlig455_034198 | Neo: - Age: - |
KREMEN1 | 3.491 | 0.940 | 0.746 | - | 0.953 | 0.852 | - | Mlig455_000683 {REF} {Length: 1382} {Pfam: WSC domain [PF01822.21, score=48.5]; PAN-like domain [PF08277.14, score=21.1]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=53.1, Expect=5e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=54.3, Expect=1e-07]} {RNA1310_39474.2} {RNA815_58746} Mlig455_000735 {REF} {Length: 1490} {Pfam: WSC domain [PF01822.21, score=36.2]; PAN domain [PF00024.28, score=20.9]} {RNA1310_36702.1} {RNA815_58746} Mlig455_034198 {REF} {Length: 685} {Pfam: WSC domain [PF01822.21, score=42.1]; PAN domain [PF00024.28, score=19.0]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.8, Expect=1e-07]} {RNA1310_148883} {RNA815_58746} |
84. | MligTC455_53580 | 10830 | 225.63 | Mlig455_061858 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.371 Region-specific R2: 2.295 Region-enriched R2: 1.602/0.00040 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
3.491 | - | 0.809 | - | 0.953 | 0.908 | 0.821 | Mlig455_061858 {REF} {Length: 1839} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=32.7]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [Score=77.4, Expect=9e-17]} {RNA1509_2808} {RNA1310_24594} {RNA815_8289} | |
85. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 3.49 | - | 0.768 | - | 0.851 | 0.904 | 0.967 | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
86. | MligTC455_53579 | 15576 | 324.49 | Mlig455_010515 | Neo: - Age: - Region-enriched R2: 1.446/0.00265 Regeneration-downregulated BL: -1.566 Regeneration-depleted BL: -1.566 |
3.488 | - | 0.779 | - | 0.973 | 0.964 | 0.772 | Mlig455_010515 {REF} {Length: 1448} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=80.3]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=2e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=5e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=119, Expect=7e-32]} {RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1310_24594, RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1509_1202, RNA1509_1348, RNA1509_17830, RNA815_8289} | |
87. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 3.488 | - | 0.753 | - | 0.948 | 0.967 | 0.820 | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
88. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
3.488 | 0.939 | - | - | 0.824 | 0.773 | 0.952 | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
89. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
3.484 | - | 0.869 | - | 0.871 | 0.776 | 0.968 | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
90. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
3.484 | 0.906 | - | - | 0.995 | 0.852 | 0.731 | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
91. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 3.455 | - | 0.861 | - | 0.857 | 0.746 | 0.991 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
92. | MligTC455_28559 | 6127 | 127.65 | Mlig455_028180 | Neo: - Age: - Region-specific R2: 2.829 Region-enriched R2: 1.854/0.00000 Regeneration-depleted BL: -1.839 |
SYT11 | 3.454 | - | 0.819 | - | 0.961 | 0.765 | 0.909 | Mlig455_028180 {REF} {Length: 2785} {Pfam: C2 domain [PF00168.32, score=161.4]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=305, Expect=7e-100]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=306, Expect=2e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=351, Expect=1e-117]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=232, Expect=2e-72]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=399, Expect=2e-137]} {RNA1509_303} {RNA1310_7615, RNA1509_303} {RNA1509_303, RNA815_4825} |
93. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 3.453 | - | 0.738 | - | 0.904 | 0.826 | 0.985 | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
94. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 3.447 | - | 0.794 | - | 0.755 | 0.920 | 0.978 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
95. | MligTC455_28560 | 6060 | 126.24 | Mlig455_028251 | Neo: - Age: - Region-specific R2: 2.839 Region-enriched R2: 1.867/0.00000 Regeneration-depleted BL: -1.887 |
SYT11 | 3.447 | - | 0.820 | - | 0.962 | 0.756 | 0.909 | Mlig455_028251 {REF} {Length: 2851} {Pfam: C2 domain [PF00168.32, score=161.3]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=304, Expect=1e-99]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=305, Expect=3e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=353, Expect=3e-118]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=233, Expect=4e-73]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=397, Expect=6e-137]} {RNA1509_17703, RNA1509_303, RNA1509_58747} {RNA1310_7615, RNA1509_17703, RNA1509_58747} {RNA1509_17703, RNA1509_58747, RNA815_4825} |
96. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
3.444 | 0.850 | - | - | 0.924 | 0.702 | 0.968 | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
97. | MligTC455_47807 | 2664 | 55.5 | Mlig455_050143 | Neo: - Age: - Region-specific R2: 3.807 Region-enriched R2: 2.561/0.00001 |
3.441 | - | 0.708 | - | 0.975 | 0.910 | 0.848 | Mlig455_050143 {REF} {Length: 1560} {RNA1509_1605, RNA1509_28756} {RNA1310_30659.1, RNA1509_28756} {RNA1509_28756, RNA815_13807} | |
98. | MligTC455_23544 | 169 | 3.53 | Mlig455_021925 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.394/0.00033 |
DDR2 | 3.436 | 0.711 | - | - | 0.983 | 0.844 | 0.898 | Mlig455_021925 {REF} {Length: 4813} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=205.5]; Protein kinase domain [PF00069.27, score=103.7]; F5/8 type C domain [PF00754.27, score=57.5]} {Human: ENSG00000162733, DDR2, discoidin domain receptor tyrosine kinase 2, [Score=249, Expect=1e-68]} {Mouse: ENSMUSG00000026674, Ddr2, discoidin domain receptor family, member 2, [Score=251, Expect=1e-69]} {Dmel: FBgn0053531, Ddr, Discoidin domain receptor, [Score=238, Expect=3e-64]} {Celegans: WBGene00017381, svh-4, Discoidin domain-containing receptor tyrosine kinase B, [Score=176, Expect=3e-45]} {Smed: dd_Smed_v6_22332_0_1, dd_Smed_v6_22332_0_1, [Score=187, Expect=2e-48]} {RNA1509_46581} {RNA1310_21361} {RNA815_21661} |
99. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 3.436 | 0.728 | - | - | 0.947 | 0.801 | 0.960 | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
100. | MligTC455_48603 | 1006 | 20.95 | Mlig455_058556 | Neo: - Age: - Region-enriched R2: 1.380/0.01205 Regeneration-downregulated BL: -2.368 Regeneration-depleted BL: -2.368 |
CALM2 | 3.436 | 0.737 | 0.757 | - | 0.972 | 0.970 | - | Mlig455_058556 {REF} {Length: 2727} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=101.0]; EF hand [PF00036.34, score=97.2]; EF-hand domain pair [PF13833.8, score=81.7]; EF-hand domain [PF13405.8, score=78.5]; EF hand [PF13202.8, score=71.6]; EF-hand domain [PF14658.8, score=41.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.3]; Dockerin type I domain [PF00404.20, score=25.5]; SurA N-terminal domain [PF13624.8, score=19.1]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=132, Expect=1e-37]; ENSG00000160014, CALM3, calmodulin 3, [Score=130, Expect=5e-37]; ENSG00000198668, CALM1, calmodulin 1, [Score=130, Expect=3e-37]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=135, Expect=8e-39]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=130, Expect=3e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=130, Expect=3e-37]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=127, Expect=3e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=127, Expect=2e-36]} {Smed: dd_Smed_v6_12048_0_2, dd_Smed_v6_12048_0_2, [RH, Score=163, Expect=8e-49]} {RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1310_6210.2, RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1509_36324, RNA1509_52694, RNA1509_5720, RNA815_4293.1} |